Dr. Carol Nacy is Founder and Chief Executive Officer, Sequella, Inc., a 17-year-old privately-held pharmaceutical company that commercializes new and more effective treatments for life-threatening infectious diseases.
Prior to Sequella, Nacy was Executive Vice President and Chief Scientific Officer at EntreMed, Inc., from 1993 through its successful public offering in June 1996. Prior to her business experience, Nacy was a career scientist and science manager for 17 years at the Walter Reed Army Institute of Research in Washington, DC.
Celebrating 25 years of innovation! 25.kgi.edu.